Positive allosteric modulator of α7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neuropharmacology

• Publication date

  2013-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuropharm.2012.10.019PMID 23168113PMCID PMC3562411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rivastigmine for Alzheimer's disease.

  2015cited by this paper
• Allosteric modulation of nicotinic acetylcholine receptors.

  2015influential reference
• PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats

  2012cited by this paper
• Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.

  2011cited by this paper
• Alzheimer's disease and age-related memory decline (preclinical).

  2011cited by this paper
• Effectiveness of Adding Memantine to an Alzheimer Dementia Treatment Regimen Which Already Includes Stable Donepezil Therapy: A Critically Appraised Topic

  2011influential reference
• Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor

  2011cited by this paper
• Investigation of the Molecular Mechanism of the α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator PNU-120596 Provides Evidence for Two Distinct Desensitized States

  2011cited by this paper
• Attention, executive functioning and memory in normal aged rhesus monkeys.

  2011cited by this paper
• Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology

  2011cited by this paper
• Age-related cognitive deficits in rhesus monkeys mirror human deficits on an automated test battery.

  2010cited by this paper
• Non-Human Primates: Model Animals for Developmental Psychopathology

  2009cited by this paper
• The unique value of primate models in translational research

  2009cited by this paper
• Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

  2008cited by this paper
• Contributions of non-human primates to neuroscience research.

  2008cited by this paper
• Hippocampal Expression Analyses Reveal Selective Association of Immediate-Early, Neuroenergetic, and Myelinogenic Pathways with Cognitive Impairment in Aged Rats

  2007cited by this paper
• The State of aging and health in America 2007

  2007cited by this paper
• Nootropic α7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators

  2007cited by this paper
• Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys

  2007cited by this paper
• Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens

  2007influential reference
• An Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo

  2007cited by this paper
• Allosteric modulation of nicotinic acetylcholine receptors.

  2007cited by this paper
• Comparison of Galantamine and Donepezil for Effects on Nerve Growth Factor, Cholinergic Markers, and Memory Performance in Aged Rats

  2006cited by this paper
• A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

  2006cited by this paper
• Cholinesterase inhibitors for Alzheimer's disease.

  2006cited by this paper
• Analysis of the Macaca mulatta transcriptome and the sequence divergence between Macaca and human

  2005cited by this paper
• Role of dopaminergic neuronal system in dizocilpine-induced acetylcholine release in the rat brain

  2005cited by this paper
• The Slow Afterhyperpolarization in Hippocampal CA1 Neurons Covaries with Spatial Learning Ability in Aged Fisher 344 Rats

  2005cited by this paper
• Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.

  2005cited by this paper
• Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys

  2005cited by this paper
• A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor: In Vitro and In Vivo Characterization

  2005influential reference
• Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis

  2004influential reference
• The medial temporal lobe.

  2004cited by this paper
• Spatial memory, recognition memory, and the hippocampus.

  2004cited by this paper
• Efficacy and Safety of Donepezil in Patients with Alzheimer’s Disease

  2004cited by this paper
• Memory Impairment in Aged Primates Is Associated with Focal Death of Cortical Neurons and Atrophy of Subcortical Neurons

  2004cited by this paper
• The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease

  2004cited by this paper
• The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure

  2003cited by this paper
• Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors

  2003cited by this paper
• The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development

  2003cited by this paper
• Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

  2003cited by this paper
• Changes to the object recognition system in patients with dementia of the Alzheimer's type.

  2002cited by this paper
• Theta-Frequency Synaptic Potentiation in CA1 In Vitro Distinguishes Cognitively Impaired from Unimpaired Aged Fischer 344 Rats

  2002cited by this paper
• Neural correlates of memory for object identity and object location: effects of aging.

  2002cited by this paper
• Animal experiments: The great primate debate

  2002cited by this paper
• Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain.

  2001cited by this paper
• A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

  2001cited by this paper
• Non‐human primates: essential partners in biomedical research

  2001cited by this paper
• Nonhuman primates: a critical role in current disease research.

  2001cited by this paper
• A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

  2001cited by this paper
• ▼Rivastigmine for Alzheimer's disease

  2000cited by this paper
• Rivastigmine for Alzheimer's disease.

  2000cited by this paper
• Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients.

  2000cited by this paper
• Decreased Protein Levels of Nicotinic Receptor Subunits in the Hippocampus and Temporal Cortex of Patients with Alzheimer’s Disease

  2000cited by this paper
• On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.

  2000cited by this paper
• Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice

  2000cited by this paper
• Galantamine in AD

  2000cited by this paper
• Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension

  2000cited by this paper
• Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.

  2000cited by this paper
• Cholinesterase Inhibitors Stabilize Alzheimer's Disease

  2000cited by this paper
• Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.

  1999cited by this paper
• The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1

  1999cited by this paper
• Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway.

  1999cited by this paper
• Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy.

  1999cited by this paper
• The use of timing behaviors in animals and humans to detect drug and/or toxicant effects.

  1999cited by this paper
• Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans.

  1998cited by this paper
• Impaired recognition memory in patients with lesions limited to the hippocampal formation.

  1997cited by this paper
• Localization of ubiquitin in the plaques of five aged primates by dual-label fluorescent immunohistochemistry

  1997cited by this paper
• Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance

  1996cited by this paper
• Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired

  1995cited by this paper
• The pharmacology of galanthamine and its analogues.

  1995cited by this paper
• Hippocampal and nonhippocampal contributions to place learning in rats.

  1995cited by this paper
• Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia.

  1995cited by this paper
• Cellular and molecular biology of Alzheimer's disease and animal models.

  1994cited by this paper
• Cholinesterase Inhibitors in Alzheimer's Disease

  1994cited by this paper
• Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.

  1993cited by this paper
• Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease.

  1993cited by this paper
• The neuropharmacological and neurochemical basis of place learning in the Morris water maze.

  1993cited by this paper
• Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans.

  1992cited by this paper
• Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types.

  1992cited by this paper
• Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys.

  1991cited by this paper
• Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction.

  1991cited by this paper
• The use of the Morris Water Maze in the study of memory and learning.

  1989cited by this paper
• The role of medial and lateral hippocampal perforant path lesions and object distinctiveness in rats' reaction to novelty.

  1988cited by this paper
• The neural basis of memory decline in aged monkeys.

  1988cited by this paper
• A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

  1988cited by this paper
• The performance of amnesic subjects on tests of experimental amnesia in animals: delayed matching-to-sample and concurrent learning.

  1988cited by this paper
• Primate learning tasks reveal strong impairments in patients with presenile or senile dementia of the Alzheimer type.

  1987cited by this paper
• A visual recognition memory test for the assessment of cognitive function in aging and dementia.

  1987cited by this paper
• Primate research: relevance to human learning and development.

  1987cited by this paper
• Matching- and delayed matching-to-sample performance as measures of visual processing, selective attention, and memory in aging and alcoholic individuals.

  1985cited by this paper
• Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats.

  1984cited by this paper
• Learning Skills of Anthropoids

  1970cited by this paper
• The chimpanzee central nervous system: a comparative review.

  1969cited by this paper

• The efficacy of an allosteric modulator of the alpha 7 nicotinic acetylcholine receptor in a murine model of stroke

  2025cites this paper
• A Comprehensive Review of the Antioxidant, Antimicrobial, and Therapeutic Efficacies of Black Cumin (Nigella sativa L.) Seed Oil and Its Thymoquinone

  2025cites this paper
• Inhibition of levodopa-induced abnormal involuntary movements (AIMs) using a selective α7 nicotinic positive allosteric modulator.

  2025cites this paper
• Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective

  2025cites this paper
• A positive allosteric modulator of α7 nicotinic receptor reduces levodopa-induced dyskinesias in hemi-parkinsonian mice.

  2025cites this paper
• Donepezil Improves PSD95 Expression, Mitigates Neuroinflammation via PI3K/Akt/NF‐κB and Mitochondrial Dysfunction in a Rodent Model of Subarachnoid Haemorrhage

  2025cites this paper
• Basal forebrain activation improves working memory in senescent monkeys

  2025influential citation
• α7 nicotinic acetylcholine receptors are necessary for basal forebrain activation to increase expression of the nerve growth factor receptor TrkA

  2024cites this paper
• Basal forebrain activation improves working memory in senescent monkeys

  2024cites this paper
• Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction

  2024cites this paper
• Exposing the latent phenotype of Gulf War Illness: examination of the mechanistic mediators of cognitive dysfunction

  2024cites this paper
• Modulation of Ca2+ oscillation following ischemia and nicotinic acetylcholine receptors in primary cortical neurons by high-throughput analysis

  2024cites this paper
• Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease.

  2023cites this paper
• Effect of woohwangchungsimwon and donepezil co-treatment on cognitive function and serum metabolic profiles in a scopolamine-induced model of Alzheimer's disease.

  2023cites this paper
• Activation of Cholinergic Anti-Inflammatory Pathway Ameliorates Cerebral and Cardiac Dysfunction After Intracerebral Hemorrhage Through Autophagy

  2022cites this paper
• The α7 nAChR allosteric modulator PNU-120596 amends neuroinflammatory and motor consequences of parkinsonism in rats: Role of JAK2/NF-κB/GSk3β/ TNF-α pathway.

  2022cites this paper
• Activation of α7 nicotinic acetylcholine receptor promotes HIV-1 transcription

  2022cites this paper
• M1-selective muscarinic allosteric modulation enhances cognitive flexibility and effective salience in nonhuman primates

  2022cites this paper
• The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders

  2022cites this paper
• Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease

  2022cites this paper
• An Overview of the Neuropharmacological Potential of Thymoquinone and its Targeted Delivery Prospects for CNS Disorder.

  2022cites this paper
• HTS-based discovery and optimization of novel positive allosteric modulators of the α7 nicotinic acetylcholine receptor.

  2021cites this paper
• Aged rhesus monkeys: cognitive performance categorizations and preclinical drug testing.

  2021cites this paper
• Title page

  2021influential citation
• A cellular approach to understanding and treating Gulf War Illness

  2021cites this paper
• Effects of nicotinic antagonists on working memory performance in young rhesus monkeys.

  2021cites this paper
• Dose-Dependent Dissociation of Pro-cognitive Effects of Donepezil on Attention and Cognitive Flexibility in Rhesus Monkeys

  2021cites this paper
• Differential effects of alkaloids on memory in rodents

  2021cites this paper
• Alpha 7 nicotinic receptor agonist and positive allosteric modulators improved social and molecular deficits of MK-801 model of schizophrenia in rats.

  2020cites this paper
• Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats.

  2020cites this paper
• LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization.

  2020cites this paper
• Studies of Learning Skills with Different Levels of Difficulty in Hamadryas Baboons (Papio hamadryas)

  2020cites this paper
• Enhancing Therapeutic Efficacy of Donepezil by Combined Therapy; A Comprehensive Review.

  2020cites this paper
• α7 Nicotinic Receptor Agonist and Positive Allosteric Modulators Differently Improved Schizophrenia-like Cognitive Deficits in Male Rats.

  2020cites this paper
• Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats

  2020cites this paper
• The α7 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-α in the hippocampus in mice

  2019cites this paper
• Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice.

  2019cites this paper
• Nicotine-like discriminative stimulus effects of acetylcholinesterase inhibitors and a muscarinic receptor agonist in Rhesus monkeys

  2019cites this paper
• Alpha‐7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide‐induced anxiety, cognitive deficit and depression‐like behaviors in mice

  2019cites this paper
• Glycogen synthase kinase-3 inhibition as a potential pharmacological target for vascular dementia: In silico and in vivo evidence

  2019cites this paper
• Facilitation and inhibition of firing activity and N-methyl-D-aspartate-evoked responses of CA1 hippocampal pyramidal cells by alpha7 nicotinic acetylcholine receptor selective compounds in vivo

  2019cites this paper
• Lynx Prototoxins: Roles of Endogenous Mammalian Neurotoxin-Like Proteins in Modulating Nicotinic Acetylcholine Receptor Function to Influence Complex Biological Processes

  2019cites this paper
• Atomoxetine improves memory and other components of executive function in young-adult rats and aged rhesus monkeys.

  2019influential citation
• Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.

  2019cites this paper
• Discovery of novel, potent, brain-permeable and orally efficacious positive allosteric modulator of alpha 7 nicotinic acetylcholine receptor [4-(5-(4-chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide], structure activity relationship and preclinical characterization.

  2019cites this paper
• Effect of nicotine and alpha‐7 nicotinic modulators on visceral pain‐induced conditioned place aversion in mice

  2018cites this paper
• Title Page

  2018influential citation
• Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors

  2018cites this paper
• The Neuroprotective Effects of Thymoquinone: A Review

  2018cites this paper
• The dual‐gate model for pentameric ligand‐gated ion channels activation and desensitization

  2018cites this paper
• The Role of Human α7-Nicotinic Acetylcholine Receptors in Mediating Neuroprotective Action of Curcumin

  2018cites this paper
• Nicotinic Receptor Ligands and Novel Object Recognition

  2018cites this paper
• Effects of alpha‐7 nicotinic allosteric modulator PNU 120596 on depressive‐like behavior after lipopolysaccharide administration in mice

  2018cites this paper
• Neuroprotective effect of the ethanol extract of Artemisia capillaris on transient forebrain ischemia in mice via nicotinic cholinergic receptor.

  2018cites this paper
• Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery

  2018cites this paper
• Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model

  2018cites this paper
• The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials

  2017cites this paper
• The α7-nACh nicotinic receptor and its role in memory and selected diseases of the central nervous system.

  2017cites this paper
• Role of cholinergic receptors in memory retrieval depends on gender and age of memory

  2017cites this paper
• Cholinergic Protection in Ischemic Brain Injury

  2017cites this paper
• 3‐Furan‐2‐yl‐N‐p‐tolyl‐acrylamide, a positive allosteric modulator of the &agr;7 nicotinic receptor, reverses schizophrenia‐like cognitive and social deficits in rats

  2017cites this paper
• Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats

  2017cites this paper
• Intermittent Stimulation of the Nucleus Basalis of Meynert Improves Working Memory in Adult Monkeys.

  2017cites this paper
• Tropisetron sensitizes &agr;7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory‐related task performance in young and aged animals

  2017cites this paper
• The wonderland of neuronal nicotinic acetylcholine receptors

  2017cites this paper
• Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia.

  2016cites this paper
• nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

  2016cites this paper
• Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.

  2016cites this paper
• α7 nicotinic acetylcholine receptors: regulation of plasticity and network activity in the prelimbic cortex

  2016cites this paper
• Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse.

  2016cites this paper
• Effects of alpha-7 nicotinic acetylcholine receptor positive allosteric modulator on lipopolysaccharide-induced neuroinflammatory pain in mice.

  2016cites this paper
• Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease.

  2016cites this paper
• Allosteric Modulation of Nicotinic Acetylcholine Receptors: The Concept and Therapeutic Trends.

  2016cites this paper
• The Effect of Thymoquinone, α7 Receptor Agonist and α7 Receptor Allosteric Modulator on the Cerebral Cortex in Experimentally Induced Alzheimer’s Disease in Relation to MSCs Activation

  2016influential citation
• Role of Microglial α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator in Neuroinflammatory Pain Models in Mice

  2016cites this paper
• Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery

  2016cites this paper
• High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-concept.

  2015cites this paper
• Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys

  2015cites this paper
• Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.

  2015cites this paper
• Allosteric modulation of nicotinic acetylcholine receptors.

  2015cites this paper
• Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia.

  2015cites this paper
• Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats.

  2015cites this paper
• Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker

  2015cites this paper
• Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.

  2015cites this paper
• Positive Allosteric Modulators of the Alpha7 Nicotinic Acetylcholine Receptor Potentiate Glutamate in Prefrontal Cortex: In Vivo Evidence for a Novel Class of Schizophrenia Treatments

  2015cites this paper
• Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury

  2015cites this paper
• R-(+) and S-(−) Isomers of Cotinine Augment Cholinergic Responses In Vitro and In Vivo

  2015cites this paper
• Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors

  2015influential citation
• α7 Nicotinic Receptor Modulation Alters Glutamate Release: Implications for Cognitive Deficits in Schizophrenia

  2015cites this paper
• Effect of alpha-7 nicotinic acetylcholine receptor activation on beta-amyloid induced recognition memory impairment. Possible role of neurovascular function.

  2015cites this paper
• Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders.

  2015cites this paper
• Pro‐cognitive activity in rats of 3‐furan‐2‐yl‐N‐p‐tolyl‐acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor

  2015influential citation
• α7 nicotinic receptor agonists reduce levodopa‐induced dyskinesias with severe nigrostriatal damage

  2015cites this paper
• R-( 1 ) and S-( 2 ) Isomers of Cotinine Augment Cholinergic Responses In Vitro and In Vivo

  2015cites this paper
• A facile synthesis of tricyclic skeleton of alkaloid 261C by double [3+2] cycloaddition of pyridinium ylide

  2015cites this paper
• Characterization of RO 5126946 , a Novel a 7 Nicotinic Acetylcholine Receptor – Positive Allosteric Modulator s

  2014influential citation
• Allosteric Modulation as a Therapeutic Alternative to Orthosteric Activation in Nicotinic Acetylcholine Receptors

  2014cites this paper
• Deficits of synaptic functions in hippocampal slices prepared from aged mice null α7 nicotinic acetylcholine receptors.

  2014cites this paper
• The therapeutic promise of positive allosteric modulation of nicotinic receptors.

  2014cites this paper
• Characterization of RO5126946, a Novel α7 Nicotinic Acetylcholine Receptor–Positive Allosteric Modulator

  2014cites this paper